
Tradewind BioScience
Tradewind BioScience is a YC Winter 2018 (W18) company. Based in San Francisco, CA, USA. Team of 2.
About Tradewind BioScience
Summary
Tradewind BioScience develops antibody therapeutics for aggressive metastatic cancers. Its lead program targets ovarian cancer with a single antibody designed to attack primary tumor cells directly while also activating the immune system's own anti-cancer response. The company pairs its drug development with companion diagnostics to identify which patients stand to benefit most from each treatment.
From the Y Combinator listing
Tradewind translates scientific insight into innovative ways of…
Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.
Facts
- Healthcare / Healthcare -> Therapeutics
- San Francisco, CA, USA
- 2
- Active
- Early
Founders (1)
- Thaddeus Allen
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works